147 related articles for article (PubMed ID: 38820006)
1. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
Harper S; Kartha M; Mealing S; Borbély YM; Zehetner J
J Med Econ; 2024; 27(1):805-815. PubMed ID: 38820006
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease.
Harper S; Grodzicki L; Mealing S; Gemmill L; Goldsmith PJ; Ahmed AR
J Med Econ; 2023; 26(1):603-613. PubMed ID: 37042668
[TBL] [Abstract][Full Text] [Related]
3. Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease.
Funk LM; Zhang JY; Drosdeck JM; Melvin WS; Walker JP; Perry KA
Surgery; 2015 Jan; 157(1):126-36. PubMed ID: 25262216
[TBL] [Abstract][Full Text] [Related]
4. The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.
Comay D; Adam V; da Silveira EB; Kennedy W; Mayrand S; Barkun AN
Can J Gastroenterol; 2008 Jun; 22(6):552-8. PubMed ID: 18560633
[TBL] [Abstract][Full Text] [Related]
5. Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF) in a large healthcare system.
Ayazi S; Zaidi AH; Zheng P; Chovanec K; Chowdhury N; Salvitti M; Newhams K; Levy J; Hoppo T; Jobe BA
Surg Endosc; 2020 May; 34(5):2279-2286. PubMed ID: 31376004
[TBL] [Abstract][Full Text] [Related]
6. LINX
Skubleny D; Switzer NJ; Dang J; Gill RS; Shi X; de Gara C; Birch DW; Wong C; Hutter MM; Karmali S
Surg Endosc; 2017 Aug; 31(8):3078-3084. PubMed ID: 27981382
[TBL] [Abstract][Full Text] [Related]
7. Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD.
Reynolds JL; Zehetner J; Nieh A; Bildzukewicz N; Sandhu K; Katkhouda N; Lipham JC
Surg Endosc; 2016 Aug; 30(8):3225-30. PubMed ID: 26541730
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORD.
Bojke L; Hornby E; Sculpher M;
Pharmacoeconomics; 2007; 25(10):829-41. PubMed ID: 17887805
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation.
Goeree R; Hopkins R; Marshall JK; Armstrong D; Ungar WJ; Goldsmith C; Allen C; Anvari M
Value Health; 2011; 14(2):263-73. PubMed ID: 21402295
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of Laparoscopic Fundoplication and Magnetic Sphincter Augmentation for the Treatment of Medically Refractory GERD.
Richards WO; McRae C
Am Surg; 2018 Nov; 84(11):1762-1767. PubMed ID: 30747630
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial).
Grant AM; Boachie C; Cotton SC; Faria R; Bojke L; Epstein DM; Ramsay CR; Corbacho B; Sculpher M; Krukowski ZH; Heading RC; Campbell MK;
Health Technol Assess; 2013 Jun; 17(22):1-167. PubMed ID: 23742987
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature.
Thijssen AS; Broeders IA; de Wit GA; Draaisma WA
Surg Endosc; 2011 Oct; 25(10):3127-34. PubMed ID: 21487859
[TBL] [Abstract][Full Text] [Related]
13. Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.
Arguedas MR; Heudebert GR; Klapow JC; Centor RM; Eloubeidi MA; Wilcox CM; Spechler SJ;
Am J Gastroenterol; 2004 Jun; 99(6):1023-8. PubMed ID: 15180720
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study.
Epstein D; Bojke L; Sculpher MJ;
BMJ; 2009 Jul; 339():b2576. PubMed ID: 19654097
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease.
Warren HF; Reynolds JL; Lipham JC; Zehetner J; Bildzukewicz NA; Taiganides PA; Mickley J; Aye RW; Farivar AS; Louie BE
Surg Endosc; 2016 Aug; 30(8):3289-96. PubMed ID: 26541740
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
[TBL] [Abstract][Full Text] [Related]
17. Transoral incisionless fundoplication is cost-effective for treatment of gastroesophageal reflux disease.
McCarty TR; Jirapinyo P; James LP; Gupta S; Chan WW; Thompson CC
Endosc Int Open; 2022 Jul; 10(7):E923-E932. PubMed ID: 35845021
[No Abstract] [Full Text] [Related]
18. A budget impact analysis of a magnetic sphincter augmentation device for the treatment of medication-refractory mechanical gastroesophageal reflux disease: a United States payer perspective.
Pandolfino J; Lipham J; Chawla A; Ferko N; Hogan A; Qadeer RA
Surg Endosc; 2020 Apr; 34(4):1561-1572. PubMed ID: 31559575
[TBL] [Abstract][Full Text] [Related]
19. S148: Long-term patient-reported outcomes of laparoscopic magnetic sphincter augmentation versus Nissen fundoplication: a 5-year follow-up study.
O'Neill SM; Jalilvand AD; Colvin JS; Haisley KR; Perry KA
Surg Endosc; 2022 Sep; 36(9):6851-6858. PubMed ID: 35041056
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis.
Guidozzi N; Wiggins T; Ahmed AR; Hanna GB; Markar SR
Dis Esophagus; 2019 Nov; 32(9):. PubMed ID: 31069388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
